Brompheniramine maleate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for brompheniramine maleate and what is the scope of freedom to operate?
Brompheniramine maleate
is the generic ingredient in eight branded drugs marketed by Alpharma Us Pharms, Kv Pharm, Pharm Assoc, Usl Pharma, Watson Labs, Wyeth Ayerst, Wyeth Cons, Barr, Ivax Sub Teva Pharms, Newtron Pharms, Nexgen Pharma Inc, Par Pharm, Pioneer Pharms, Upsher Smith Labs, Vitarine, Wockhardt, Wockhardt Bio Ag, Acella, Alkem Labs Ltd, Bionpharma, Chartwell Molecular, Dr Reddys Labs Sa, Padagis Us, Rhodes Pharms, Taro, Wes Pharma Inc, Robins Ah, and Alza, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.There are seventeen drug master file entries for brompheniramine maleate.
Summary for brompheniramine maleate
| US Patents: | 0 |
| Tradenames: | 8 |
| Applicants: | 28 |
| NDAs: | 33 |
| Drug Master File Entries: | 17 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 4 |
| Patent Applications: | 1,997 |
| DailyMed Link: | brompheniramine maleate at DailyMed |
Recent Clinical Trials for brompheniramine maleate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
Medical Subject Heading (MeSH) Categories for brompheniramine maleate
Anatomical Therapeutic Chemical (ATC) Classes for brompheniramine maleate
US Patents and Regulatory Information for brompheniramine maleate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | BROMPHENIRAMINE MALEATE | brompheniramine maleate | TABLET;ORAL | 084468-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Cons | DIMETANE | brompheniramine maleate | TABLET, EXTENDED RELEASE;ORAL | 010799-011 | Jun 10, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | BROMPHENIRAMINE MALEATE | brompheniramine maleate | INJECTABLE;INJECTION | 083820-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Cons | DIMETANE | brompheniramine maleate | TABLET, EXTENDED RELEASE;ORAL | 010799-010 | Jun 10, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
